Julie Riopel

Lafront C, Germain L, Campolina-Silva GH, Weidmann C, Berthiaume L, Hovington H, Brisson H, Jobin C, Frégeau-Proulx L, Cotau R, Gonthier K, Lacouture A, Caron P, Ménard C, Atallah C, Riopel J, Latulippe É, Bergeron A, Toren P, Guillemette C, Pelletier M, Fradet Y, Belleannée C, Pouliot F, Lacombe L, Lévesque É, Audet-Walsh É

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression

J Clin Invest, 134 (11), 2024.

Résumé | Liens:

Désy O, Béland S, Thivierge MP, Marcoux M, Desgagnés JS, Bouchard-Boivin F, Gama A, Riopel J, Latulippe E, De Serres SA

T follicular helper cells expansion in transplant recipients correlates with graft infiltration and adverse outcomes

Front Immunol, 15 , 2024.

Résumé | Liens:

Bergeron NAD, Garneau AP, Rousseau-Gagnon M, Riopel J, Isenring P

X-linked Alport syndrome presenting in mother and son with the same unique histopathological features

J Nephrol, 37 (3), 2024.

Résumé | Liens:

Rioux AV, Bergeron NA, Riopel J, Marcoux N, Thériault C, Gould PV, Garneau AP, Isenring P

The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications

J Mol Med (Berl), 101 (10), 2023.

Résumé | Liens:

El Yamani N, Cote G, Riopel J, Marcoux N, Mac-Way F, Philibert D, Agharazii M

Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report

Kidney Med, 5 (8), 2023.

Résumé | Liens:

Gonthier K, Weidmann C, Berthiaume L, Jobin C, Lacouture A, Lafront C, Harvey M, Neveu B, Loehr J, Bergeron A, Fradet Y, Lacombe L, Riopel J, Latulippe É, Atallah C, Shum M, Lambert JP, Pouliot F, Pelletier M, Audet-Walsh É

Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer

Mol Oncol, 17 (10), 2023.

Résumé | Liens:

Béland S, Désy O, El Fekih R, Marcoux M, Thivierge MP, Desgagné JS, Latulippe E, Riopel J, Wagner E, Rennke HG, Weins A, Yeung M, Lapointe I, Azzi J, De Serres SA

Expression of Class II Human Leukocyte Antigens on Human Endothelial Cells Shows High Interindividual and Intersubclass Heterogeneity

J Am Soc Nephrol, 34 (5), 2023.

Résumé | Liens:

Ouellet G, Houde I, Riopel J, Latulippe E, Douville P, Lesage J, Côté I, Lapointe I, De Serres SA

The Progression of Interstitial Fibrosis and Tubular Atrophy at 6 Months Is an Independent Predictor of Poor Graft Outcomes in Kidney Transplant Recipients

Transplant Direct, 8 (12), 2022.

Résumé | Liens:

Champagne A, Jain P, Vélot L, Riopel J, Lefebvre V, Neveu B, Pouliot F

A transcriptional biosensor to monitor single cancer cell therapeutic responses by bioluminescence microscopy

Theranostics, 12 (2), 2022.

Résumé | Liens:

Meziou S, Ringuette Goulet C, Hovington H, Lefebvre V, Lavallée É, Bergeron M, Brisson H, Champagne A, Neveu B, Lacombe D, Beauregard JM, Buteau FA, Riopel J, Pouliot F

GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome

Prostate Cancer Prostatic Dis, 23 (3), 2020.

Résumé | Liens: